Jonathan Robert Hunt - 12 Dec 2023 Form 4 Insider Report for Perspective Therapeutics, Inc. (CATX)

Role
Chief Financial Officer
Signature
/s/ Jonathan Hunt
Issuer symbol
CATX
Transactions as of
12 Dec 2023
Net transactions value
$0
Form type
4
Filing time
14 Dec 2023, 18:36:47 UTC
Previous filing
05 Dec 2022
Next filing
19 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CATX Stock Options (right to buy) Award $0 +1,248,776 +98% $0.000000 2,527,429 12 Dec 2023 Common Stock 1,248,776 $0.2400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% vested as of 12/12/2023, and the remaining 75% will vest over the next three (3) years, commencing on 12/12/2024, until fully vested.